ArticleFrontiers in pharmacology2021

A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.